BMEA: Biomea Fusion, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 101.47
Enterprise Value ($M) 13.52
Book Value ($M) 75.97
Book Value / Share 2.10
Price / Book 1.34
NCAV ($M) 59.15
NCAV / Share 1.63
Price / NCAV 1.72

Profitability (mra)
Return on Invested Capital (ROIC) -1.68
Return on Assets (ROA) -0.72
Return on Equity (ROE) -0.85

Liquidity (mrq)
Quick Ratio 3.39
Current Ratio 3.39

Balance Sheet (mrq) ($M)
Current Assets 93.60
Assets 110.42
Liabilities 34.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Baker Bros. Advisors Lp 4.00 -31.15
11-12 13G/A Laurion Capital Management LP 0.00 -100.00
07-10 13G/A State Street Corp 1.88 -84.94
2024-02-12 13G/A Janus Henderson Group Plc 4.80 -37.68
2024-02-12 13G/A Butler Thomas Andrew 10.40 10.13
2024-02-12 13G/A Erdtmann Rainer M 7.80 4.21
2024-02-09 13G/A Fmr Llc 15.00 7.23

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 50,879 338,413 15.03
2025-03-06 567,839 1,106,776 51.31
2025-03-05 173,992 583,127 29.84
2025-03-04 171,168 751,739 22.77

(click for more detail)

Similar Companies
BEAM – Beam Therapeutics Inc. BIIB – Biogen Inc.
BLUE – bluebird bio, Inc. BMRN – BioMarin Pharmaceutical Inc.
BPMC – Blueprint Medicines Corporation


Financial data and stock pages provided by
Fintel.io